Medication info
Hutradol Semi Tablet

Hutradol Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
HuoNS Co., Ltd.
Appearance
Light yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200712587 · Notified 2007.11.19 · Insurance code 670604310

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance of less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
HuoNS Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance of less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication can burden the liver; therefore, individuals who consistently consume alcohol in excess of a certain amount daily must consult a physician or pharmacist before taking it. If skin rashes or allergic reactions occur during use, discontinue immediately and seek medical attention. Care should be taken when used in combination with certain antidepressants or other central nervous system drugs due to the risk of seizures. This medication can occasionally cause severe allergic reactions; thus, if symptoms such as difficulty breathing or hives occur, immediate medical attention should be sought. Patients with severe respiratory diseases may experience life-threatening respiratory depression when taking this medication, so it should be administered under the supervision of healthcare professionals. Avoid taking it with alcohol or sedatives, as this may lead to severe drowsiness or respiratory depression, which are dangerous side effects. Patients with head injuries or elevated intracranial pressure need to be cautious as the respiratory depressing effects of this drug can exacerbate their symptoms. This medication may cause physical and psychological dependence, so usage should adhere to a physician’s guidance if taken long-term. Patients with poor liver function must consult a physician before taking this medication and avoid exceeding the recommended daily dose. Patients with certain genetic metabolic disorders may experience rapid metabolism of this drug’s components in the body, leading to severe side effects, so consulting a physician before use is necessary. This medication is not to be administered to children under 12 years of age or individuals under 18 years who have undergone tonsillectomy or adenoidectomy. This medication may induce sleep apnea or hypoxemia, so if such symptoms are suspected, immediate consultation with healthcare providers is advised. Elderly patients or those at risk for hyponatremia should closely monitor for symptoms of hyponatremia while taking this medication. This medication is contraindicated for patients with specific conditions or those taking certain medications; always inform the doctor of current medications and health status before use. Drowsiness or dizziness may occur during use, so caution is advised when driving or operating dangerous machinery. Overdose may result in serious respiratory depression or liver damage, so adherence to prescribed doses and timing is essential. Avoid alcohol consumption while taking this medication and refrain from taking other analgesics or central nervous system depressants concurrently. Discontinuation should not be abrupt as withdrawal symptoms may occur; taper off gradually per physician’s instructions. If any adverse reactions or discomfort occur during use, consult healthcare providers immediately to receive appropriate guidance.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, profound sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnolence, sensory loss, tremors, sensory disturbances, attention disorders, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disturbances, erectile dysfunction, asthenia, chest pain, abnormal emotions, chills, chest discomfort, malaise, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, influence on unstable emotions, delirium, suicidal thoughts, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, confusion, worsening of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, polyuria, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, tinnitus, chills, buttock pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eyes, progression of liver cancer, liver function abnormalities, nausea, constipation, vomiting, dizziness, headache, vertigo, confusion, agitation, multiple organ failure, intentional overdose, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, upper respiratory syndrome, lip tremor, agitation, nervousness, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, toxic skin necrosis, bronchospasm, opioid-induced hyperalgesia, symptoms of acute or chronic adrenal insufficiency (severe abdominal pain, nausea, vomiting, hypotension, extreme fatigue, loss of appetite, weight loss)

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air ingress, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.